Behavioural intention to adopt pharmacogenomics and its predicting factors in Malaysia

Muhammad Adzran Che Mustapa, Latifah Amin, Muhammad Rizal Razman

Research output: Contribution to journalArticle

Abstract

Advances in pharmacogenomics technology research have, to a great extent, uncovered the differences in the genetic basis of interindividual responses to medication. Pharmacogenomics (PGx) is an evolving area in precision medicine with the goal of identifying an individual's response to drugs, detecting those at risk of developing adverse events, and guiding healthcare providers in terms of selecting the correct drug dose. This technology is useful with regard to improving both the efficacy and the safety of drug prescribing. The successful development and implementation of this technology is highly dependent on public acceptance, which is reflected in their intention to adopt this technology. Therefore, this paper aims to assess the intention of the Malaysian stakeholders to adopt PGx and its associated predictors. Results of the study showed that the Malaysian stakeholders were moderately engaged with medical genetics, have high trust in the key players and were highly religious. Additionally they perceived PGx as highly beneficial and rated the risks and moral aspects as moderate which translated into high intention to adopt PGx.

Original languageEnglish
JournalAcademy of Strategic Management Journal
Volume18
Issue number1
Publication statusPublished - 1 Jan 2019

Fingerprint

Factors
Pharmacogenomics
Behavioral intention
Malaysia
Drugs
Stakeholders
Adverse events
Predictors
Medication
Efficacy
Safety
Medicine
Prescribing
Healthcare
Public acceptance

Keywords

  • Behavioural intentions
  • Malaysia
  • Pharmacogenomics
  • Predictors

ASJC Scopus subject areas

  • Business and International Management
  • Strategy and Management

Cite this

Behavioural intention to adopt pharmacogenomics and its predicting factors in Malaysia. / Che Mustapa, Muhammad Adzran; Amin, Latifah; Razman, Muhammad Rizal.

In: Academy of Strategic Management Journal, Vol. 18, No. 1, 01.01.2019.

Research output: Contribution to journalArticle

@article{0a19dac41235401cb649d51596016d45,
title = "Behavioural intention to adopt pharmacogenomics and its predicting factors in Malaysia",
abstract = "Advances in pharmacogenomics technology research have, to a great extent, uncovered the differences in the genetic basis of interindividual responses to medication. Pharmacogenomics (PGx) is an evolving area in precision medicine with the goal of identifying an individual's response to drugs, detecting those at risk of developing adverse events, and guiding healthcare providers in terms of selecting the correct drug dose. This technology is useful with regard to improving both the efficacy and the safety of drug prescribing. The successful development and implementation of this technology is highly dependent on public acceptance, which is reflected in their intention to adopt this technology. Therefore, this paper aims to assess the intention of the Malaysian stakeholders to adopt PGx and its associated predictors. Results of the study showed that the Malaysian stakeholders were moderately engaged with medical genetics, have high trust in the key players and were highly religious. Additionally they perceived PGx as highly beneficial and rated the risks and moral aspects as moderate which translated into high intention to adopt PGx.",
keywords = "Behavioural intentions, Malaysia, Pharmacogenomics, Predictors",
author = "{Che Mustapa}, {Muhammad Adzran} and Latifah Amin and Razman, {Muhammad Rizal}",
year = "2019",
month = "1",
day = "1",
language = "English",
volume = "18",
journal = "Academy of Strategic Management Journal",
issn = "1544-1458",
publisher = "Allied Academies",
number = "1",

}

TY - JOUR

T1 - Behavioural intention to adopt pharmacogenomics and its predicting factors in Malaysia

AU - Che Mustapa, Muhammad Adzran

AU - Amin, Latifah

AU - Razman, Muhammad Rizal

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Advances in pharmacogenomics technology research have, to a great extent, uncovered the differences in the genetic basis of interindividual responses to medication. Pharmacogenomics (PGx) is an evolving area in precision medicine with the goal of identifying an individual's response to drugs, detecting those at risk of developing adverse events, and guiding healthcare providers in terms of selecting the correct drug dose. This technology is useful with regard to improving both the efficacy and the safety of drug prescribing. The successful development and implementation of this technology is highly dependent on public acceptance, which is reflected in their intention to adopt this technology. Therefore, this paper aims to assess the intention of the Malaysian stakeholders to adopt PGx and its associated predictors. Results of the study showed that the Malaysian stakeholders were moderately engaged with medical genetics, have high trust in the key players and were highly religious. Additionally they perceived PGx as highly beneficial and rated the risks and moral aspects as moderate which translated into high intention to adopt PGx.

AB - Advances in pharmacogenomics technology research have, to a great extent, uncovered the differences in the genetic basis of interindividual responses to medication. Pharmacogenomics (PGx) is an evolving area in precision medicine with the goal of identifying an individual's response to drugs, detecting those at risk of developing adverse events, and guiding healthcare providers in terms of selecting the correct drug dose. This technology is useful with regard to improving both the efficacy and the safety of drug prescribing. The successful development and implementation of this technology is highly dependent on public acceptance, which is reflected in their intention to adopt this technology. Therefore, this paper aims to assess the intention of the Malaysian stakeholders to adopt PGx and its associated predictors. Results of the study showed that the Malaysian stakeholders were moderately engaged with medical genetics, have high trust in the key players and were highly religious. Additionally they perceived PGx as highly beneficial and rated the risks and moral aspects as moderate which translated into high intention to adopt PGx.

KW - Behavioural intentions

KW - Malaysia

KW - Pharmacogenomics

KW - Predictors

UR - http://www.scopus.com/inward/record.url?scp=85068442204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068442204&partnerID=8YFLogxK

M3 - Article

VL - 18

JO - Academy of Strategic Management Journal

JF - Academy of Strategic Management Journal

SN - 1544-1458

IS - 1

ER -